Literature DB >> 23380419

Visceral leishmaniasis: host-parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host.

Laura Saporito1, Giovanni M Giammanco, Simona De Grazia, Claudia Colomba.   

Abstract

Visceral leishmaniases are vector-borne parasitic diseases caused by protozoa belonging to the genus Leishmania. The heterogeneity of clinical manifestations and epidemiological characteristics of the disease reflect the complex interplay between the infecting Leishmania species and the genetic and immunologic characteristics of the infected host. The clinical presentation of visceral leishmaniasis depends strictly on the immunocompetency of the host and ranges from asymptomatic to severe forms. Conditions of depression of the immune system, such as HIV infection or immunosuppressive treatments, impair the capability of the immune response to resolve the infection and allow reactivation and relapses of the disease.
Copyright © 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23380419     DOI: 10.1016/j.ijid.2012.12.024

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  20 in total

1.  Visceral Leishmaniasis in a patient with rheumatoid arthritis undergoing treatment with methotrexate: Case report and review of the literature.

Authors:  Kyriakos Trigkidis; Eleni Geladari; Evangelos Kokkinakis; Natalia Vallianou
Journal:  Eur J Rheumatol       Date:  2017-04-11

2.  Association between Insulin-Like Growth Factor-I Levels and the Disease Progression and Anemia in Visceral Leishmaniasis.

Authors:  Flaviane Alves de Pinho; Célia Maria Vieira Vendrame; Bruna Leal Lima Maciel; Lucilene Dos Santos Silva; Samantha Ive Miyashiro; Selma Maria Bezerra Jerônimo; Hiro Goto
Journal:  Am J Trop Med Hyg       Date:  2019-04       Impact factor: 2.345

3.  High levels of serum glycans monovalent IgG immune complexes detected by dissociative ELISA in experimental visceral leishmaniasis.

Authors:  Camila Aparecida de Carvalho; Thiago Fidelis Ferrão; Flávia Regina Novais de Freitas; Heitor Franco de Andrade
Journal:  Immunology       Date:  2019-10-01       Impact factor: 7.397

4.  Tumor lysis-like syndrome in a child during treatment for visceral leishmaniasis.

Authors:  Athanasios Tragiannidis; Maria Papageorgiou; Maria Stamou; Emmanuel Hatzipantelis; Theodotis Papageorgiou; Andreas Giannopoulos; Lamprini Damianidou; Anna Pappa; Stiliani Pappa; Maria Hatzistilianou
Journal:  Int J Immunopathol Pharmacol       Date:  2016-03-29       Impact factor: 3.219

5.  Visceral leishmaniasis: a differential diagnosis to remember after bone marrow transplantation.

Authors:  Margarida Dantas Brito; Fernando Campilho; Rosa Branca; Carlos Pinho Vaz; Cristina Silva; Teresa Sousa; Carlos Mendes; António Campos
Journal:  Case Rep Hematol       Date:  2014-12-11

Review 6.  Leishmaniasis-HIV coinfection: current challenges.

Authors:  José Angelo Lauletta Lindoso; Mirella Alves Cunha; Igor Thiago Queiroz; Carlos Henrique Valente Moreira
Journal:  HIV AIDS (Auckl)       Date:  2016-10-07

7.  Sera from Visceral Leishmaniasis Patients Display Oxidative Activity and Affect the TNF-α Production by Macrophages In Vitro.

Authors:  Neci M Soares; Joelma N de Souza; Tatiana F Leal; Eliana A G Reis; Maria S Miranda; Washington L C Dos Santos; Márcia C A Teixeira
Journal:  Biomed Res Int       Date:  2017-11-05       Impact factor: 3.411

8.  An unusual presentation of leishmaniasis in a human immunodeficiency virus-positive individual.

Authors:  Marijo S Roiko; Bryan H Schmitt; Ryan F Relich; Thomas L Meyer; Shanxiang Zhang; Thomas E Davis
Journal:  JMM Case Rep       Date:  2016-02-05

9.  Visceral leishmaniasis during pregnancy: A rare case report from Greece.

Authors:  Periklis Panagopoulos; Vasileios Mitsopoulos; Antonios Papadopoulos; Spyridoula Theodorou; Chrysoula Christodoulaki; Kyriakos Aloupogiannis; Nikolaos Papantoniou
Journal:  PLoS Negl Trop Dis       Date:  2017-02-16

10.  Genomic Analysis of Colombian Leishmania panamensis strains with different level of virulence.

Authors:  Daniel Alfonso Urrea; Jorge Duitama; Hideo Imamura; Juan F Álzate; Juanita Gil; Natalia Muñoz; Janny Alexander Villa; Jean-Claude Dujardin; José R Ramirez-Pineda; Omar Triana-Chavez
Journal:  Sci Rep       Date:  2018-11-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.